T 2402/10 (Prostaglandin derivatives / Pfizer) of 10.5.2012

European Case Law Identifier: ECLI:EP:BA:2012:T240210.20120510
Date of decision: 10 May 2012
Case number: T 2402/10
Application number: 02009255.7
IPC class: C07C 405/00
A61K 31/557
A61P 27/02
Language of proceedings: EN
Distribution: C
Download and more information:
Decision text in EN (PDF, 83 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
Applicant name: Pfizer Health AB
Opponent name: Breath Limited
Apotex España SL
ALAPIS S.A.
Board: 3.3.10
Headnote: -
Relevant legal provisions:
European Patent Convention Art 54
European Patent Convention Art 56
European Patent Convention Art 76(1)
European Patent Convention Art 111(1)
European Patent Convention Art 123(2)
Keywords: Amendments (allowable) - no added matter
Novelty (yes)
Inventive step (yes) - solution not obvious
Double patenting (no) - not the same subject-matter
Catchwords:

-

Cited decisions:
G 0001/05
G 0001/06
T 0548/91
T 0643/96
T 0307/03
T 0469/03
T 0936/04
T 0877/06
T 1708/06
T 1391/07
Citing decisions:
T 2461/10
T 0649/11
T 1155/11
T 1483/11
T 2563/11
T 1780/12
T 0318/14

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t102402eu1.html

Date retrieved: 17 May 2021

23 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Offical Journal of the EPO

Case Law Book: I Patentability

Case Law Book: II Conditions to be met by an Application

Case Law of the Enlarged Board

General Case Law